Table 4.

Overview of Baseline Demographic and Clinical Characteristics: Intention-to-Treat Population

	n	Test Group (SMOFlipid)	n	Control Group	P Value (Test of Homogeneity)a
Gestational age, wk, mean (SD)	26	29.9 (1.9)	27	30.4 (1.8)	.195
Age at start of infusion, d, mean (SD)	26	7.0 (1.4)	27	7.3 (2.0)	.464
Gender, % of females	26	69.2	27	40.7	.054b
Birth length, cm, mean (SD)	25	38.9 (3.8)	25	39.1 (3.2)	.371
Birth weight, g, mean (SD)	27	1335.6 (408.8)	27	1364.1 (339.7)	.440
Head circumference, cm, mean (SD)	25	27.6 (2.7)	23	27.5 (2.0)	.356
Apgar score, 60 seconds, No. (%)					.683c
>8	26	11 (42.3)	27	9 (33.3)
6–8	26	10 (38.5)	27	13 (48.1)
<6	26	5 (19.2)	27	5 (18.5)
Apgar score, 300 seconds, No. (%)					.885c
>8	26	16 (61.5)	27	15 (55.6)
6–8	26	9 (34.6)	27	12 (44.4)
<6	26	1 (3.8)	27	0

^aWilcoxon 2-sample test (t approximation).

^bFisher exact test.

^cMantel-Haenszel test.